PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology

por Miglietta, Federica, Cinquini, Michela, Dieci, Maria Vittoria, Cortesi, Laura, Criscitiello, Carmen, Montemurro, Filippo, Del Mastro, Lucia, Zambelli, Alberto, Biganzoli, Laura, Levaggi, Alessia, Delle Piane, Chiara, Marchiò, Caterina, Calabrese, Massimo, Fortunato, Lucio, Franco, Pierfrancesco, Meduri, Bruno, Fittipaldo, Veronica Andrea, Gori, Stefania
Publicado 2022